These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18428168)

  • 1. Sensitive NMR sensors detect antibodies to influenza.
    Koh I; Hong R; Weissleder R; Josephson L
    Angew Chem Int Ed Engl; 2008; 47(22):4119-21. PubMed ID: 18428168
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemagglutinin stem reactive antibody response in individuals immunized with a seasonal influenza trivalent vaccine.
    Zhao X; Qin K; Guo J; Wang D; Li Z; Zhu W; Liu L; Wang D; Shu Y; Zhou J
    Protein Cell; 2015 Jun; 6(6):453-457. PubMed ID: 25940943
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigen distortion allows influenza virus to escape neutralization.
    Fleury D; Wharton SA; Skehel JJ; Knossow M; Bizebard T
    Nat Struct Biol; 1998 Feb; 5(2):119-23. PubMed ID: 9461077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stalking influenza diversity with a universal antibody.
    Russell CJ
    N Engl J Med; 2011 Oct; 365(16):1541-2. PubMed ID: 22010922
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of next generation hemagglutinin-based broadly protective influenza virus vaccines.
    Nachbagauer R; Palese P
    Curr Opin Immunol; 2018 Aug; 53():51-57. PubMed ID: 29680576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans.
    Nachbagauer R; Choi A; Izikson R; Cox MM; Palese P; Krammer F
    mBio; 2016 Jan; 7(1):e01996-15. PubMed ID: 26787832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Influenza Virus Hemagglutinin Stalk-Specific Antibody Responses.
    Liu WC; Nachbagauer R; Krammer F; Albrecht RA
    Methods Mol Biol; 2018; 1836():487-511. PubMed ID: 30151588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.
    Leon PE; He W; Mullarkey CE; Bailey MJ; Miller MS; Krammer F; Palese P; Tan GS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(40):E5944-E5951. PubMed ID: 27647907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza Hemagglutinin Structures and Antibody Recognition.
    Wu NC; Wilson IA
    Cold Spring Harb Perspect Med; 2020 Aug; 10(8):. PubMed ID: 31871236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadly neutralizing antibodies against influenza viruses.
    Laursen NS; Wilson IA
    Antiviral Res; 2013 Jun; 98(3):476-83. PubMed ID: 23583287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and Structure of an Engineered Disulfide-Stabilized Influenza Virus Hemagglutinin Trimer.
    Lee PS; Zhu X; Yu W; Wilson IA
    J Virol; 2015 Jul; 89(14):7417-20. PubMed ID: 25926650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site.
    Fleury D; Barrère B; Bizebard T; Daniels RS; Skehel JJ; Knossow M
    Nat Struct Biol; 1999 Jun; 6(6):530-4. PubMed ID: 10360354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance.
    Chen YQ; Lan LY; Huang M; Henry C; Wilson PC
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the antigenic relatedness of influenza virus haemagglutinins with strain-specific polyclonal antibodies.
    García-Barreno B; Delgado T; Benito S; Casas I; Pozo F; Melero JA
    J Gen Virol; 2014 Oct; 95(Pt 10):2140-2145. PubMed ID: 25000959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of antibody CR6261 V(H) and scFv expression on influenza virus infection].
    Li Y; Li X; Yan J
    Sheng Wu Gong Cheng Xue Bao; 2011 Oct; 27(10):1472-81. PubMed ID: 22260064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shaping a universally broad antibody response to influenza amidst a variable immunoglobulin landscape.
    Andrews SF; McDermott AB
    Curr Opin Immunol; 2018 Aug; 53():96-101. PubMed ID: 29730560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of a rapid diagnostic application of monoclonal antibodies against avian influenza H7 subtype virus using Europium nanoparticles.
    Yeo SJ; Bao DT; Seo GE; Bui CT; Kim DTH; Anh NTV; Tien TTT; Linh NTP; Sohn HJ; Chong CK; Shin HJ; Park H
    Sci Rep; 2017 Aug; 7(1):7933. PubMed ID: 28801679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.
    Khurana S; Loving CL; Manischewitz J; King LR; Gauger PC; Henningson J; Vincent AL; Golding H
    Sci Transl Med; 2013 Aug; 5(200):200ra114. PubMed ID: 23986398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide.
    Kostolanský F; Mucha V; Slováková R; Varecková E
    Acta Virol; 2002; 46(4):229-36. PubMed ID: 12693859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.